Factors Affecting Survival in Patients with Metastatic Spinal Cord Compression
Author Information
Author(s): Mirza Pojskić, Benjamin Saß, Miriam H. A. Bopp, Sebastian Wilke, Christopher Nimsky
Primary Institution: Department of Neurosurgery, University of Marburg
Hypothesis
What factors influence overall and readmission-free survival in patients with metastatic epidural spinal cord compression?
Conclusion
Surgical treatment for metastatic spinal tumors can improve outcomes, with better prognostic scores linked to longer survival.
Supporting Evidence
- Patients with a Tomita score < 7 had a median overall survival of 132 days.
- Adjuvant radiotherapy was associated with a longer overall survival of 217.4 days.
- Patients with ECOG ≤ 2 had a median overall survival of 188 days.
- Postoperative improvement in neurological function was linked to a median overall survival of 186 days.
- Complications after surgery significantly reduced overall survival to 60 days.
Takeaway
This study looked at patients with cancer who had problems with their spine. It found that surgery can help them feel better and live longer, especially if they have good health scores.
Methodology
This was a retrospective observational study of patients who underwent surgery for metastatic epidural spinal cord compression from 2018 to 2022.
Potential Biases
Potential biases due to the retrospective nature and lack of a control group.
Limitations
The study is retrospective and involved multiple surgeons, which may affect the consistency of outcomes.
Participant Demographics
The cohort included 175 patients, with 71 females and a median age of 67. Most had lung or prostate cancer.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI: 23.5–240.5
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website